Hong Du
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- Glycosylation and Glycoproteins Research 2
- Cancer therapeutics and mechanisms 2
- Oncology 4
- Cancer Treatment and Pharmacology 2
- Drug Transport and Resistance Mechanisms 2
- Co-authors
- Yuanjie Shi (2 shared papers)Boyi Song (2 shared papers)Ershuai Zhang (2 shared papers)Xiangfei Han (2 shared papers)Ke Wang (1 shared paper)Chengbiao Yang (1 shared paper)Zhiqiang Cao (1 shared paper)Jinbing Xie (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (3 papers)Molecules (2 papers)Toxins (1 paper)Molecular Cancer Therapeutics (1 paper)Nature Nanotechnology (1 paper)
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Hong Du
18 papers receiving 615 citations
Hong Du's Hit Papers
Peers
Comparison fields: 5 of 97
- Pharmaceutical Science 149
- Biomaterials 82
- Cancer Research 73
- Molecular Biology 250
- Surfaces, Coatings and Films 25
Countries citing papers authored by Hong Du
This map shows the geographic impact of Hong Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Du more than expected).
Fields of papers citing papers by Hong Du
This network shows the impact of papers produced by Hong Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Du. The network helps show where Hong Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Hong Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Zwitterionic micelles efficiently deliver oral insulin without opening tight junctions Hit paper breakdown → | 2020 | 255 |
| 2 | 2009 | 90 | |
| 3 | 2020 | 68 | |
| 4 | 2019 | 36 | |
| 5 | 2011 | 21 | |
| 6 | 2011 | 19 | |
| 7 | 2023 | 19 | |
| 8 | 2011 | 17 | |
| 9 | 2021 | 17 | |
| 10 | 2022 | 16 | |
| 11 | 2022 | 14 | |
| 12 | 2023 | 12 | |
| 13 | 2011 | 12 | |
| 14 | 2023 | 10 | |
| 15 | 2023 | 6 | |
| 16 | 2024 | 3 | |
| 17 | 2021 | 2 | |
| 18 | 2023 | 2 |
About Hong Du
Hong Du is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Pharmacology, having authored 18 papers that have together received 619 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (2 papers), Cancer Treatment and Pharmacology (2 papers), Fluoride Effects and Removal (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Pharmacological Effects of Natural Compounds (2 papers), Prostate Cancer Treatment and Research (2 papers), Cancer therapeutics and mechanisms (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Pharmaceutical Science (149 citations), Biomaterials (82 citations), Cancer Research (73 citations), Molecular Biology (250 citations) and Surfaces, Coatings and Films (25 citations). Hong Du has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Yuanjie Shi, Boyi Song, Ershuai Zhang, Xiangfei Han, Ke Wang, Chengbiao Yang, Zhiqiang Cao, Jinbing Xie, Yang Lü and Hui Zhu. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Molecules, Toxins, Molecular Cancer Therapeutics and Nature Nanotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.